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113Contralateral occlusion of the internal carotid artery
increases the risk of patients undergoing carotid
endarterectomy
George A. Antoniou, MD, PhD,a Ganesh Kuhan, MD, FRCS,a George S. Sfyroeras, MD, PhD,b
George S. Georgiadis, MD,c Stavros A. Antoniou, MD,d David Murray, MD, FRCS,a and
Ferdinand Serracino-Inglott, MD, FRCS,a,e Manchester, United Kingdom; Athens and Alexandroupolis, Greece;
and Marburg, Germany
Background: Controversy exists about whether occlusion of the contralateral internal carotid artery in patients under-
going carotid endarterectomy (CEA) is associated with a worse perioperative prognosis and outcome.
Methods: A systematic review of electronic information sources was undertaken to identify studies comparing perioperative
and early outcomes of CEA in patients with occluded and patent contralateral carotid arteries. The methodologic quality
of selected studies was independently appraised by two reviewers. Fixed- and random-effects models were applied to
synthesize outcome data.
Results: Our literature search located 46 articles eligible for inclusion in the review and analysis. The total population
comprised 27,265 patients having undergone 28,846 CEAs (occluded contralateral artery group, 3120; patent contra-
lateral artery group, 25,726). Patients with an occluded contralateral carotid artery had increased incidence of stroke
(odds ratio [OR], 1.65, 95% conﬁdence interval [CI], 1.30-2.09), transient ischemic attack (OR, 1.57, 95% CI, 1.11-
2.21), stroke/transient ischemic attack (OR, 1.52; 95% CI, 1.21-1.90), and death (OR, 1.76; 95% CI, 1.19-2.59) #30
days of treatment compared with those with a patent contralateral vessel. No difference in the incidence of myocardial
infarction between the two groups was identiﬁed (OR, 1.45; 95% CI, 0.73-2.89).
Conclusions: Patients undergoing CEA in the presence of an occluded contralateral carotid artery had increased peri-
operative and early postoperative risk. Our analysis is limited by heterogeneity in symptom status and practices of
intraoperative cerebral protection among the studies. Careful consideration should be given in this subgroup of patients
with regard to selection and perioperative and postoperative care to minimize the risk. (J Vasc Surg 2013;57:1134-45.)Carotid endarterectomy (CEA) has been established as
an effective intervention for stroke prevention in patients
with signiﬁcant symptomatic and asymptomatic carotid
stenosis.1 Patients receiving surgical treatment of extracra-
nial carotid disease in the presence of contralateral internal
carotid artery occlusion represent a distinct subgroup of
patients who, theoretically, have increased perioperative
risks of adverse cerebrovascular events and mortality.2,3
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4and an overall more advanced state of vascular disease,
which constitute poor prognostic factors associated with
surgical carotid intervention.
Previous studies have shown conﬂicting results
regarding the risk for this subset of patients undergoing
CEA. The North American Symptomatic Carotid Endar-
terectomy Trial (NASCET) identiﬁed occlusion of the
contralateral artery as a factor adversely affecting the early
and late outcome of CEA,3 whereas post hoc analysis of
the Asymptomatic Carotid Atherosclerosis Study revealed
that contralateral occlusion did not inﬂuence the surgical
outcome.4 However, these trials are limited by few
numbers of patients with contralateral carotid occlusion
in their surgical arms.
Several reports evaluating the safety of CEA in this
subgroup of patients have demonstrated no signiﬁcant
difference in the early results, expressed by morbidity and
mortality of neurologic etiology, in patients with and
without contralateral vessel occlusion.5 Nevertheless, closer
evaluation of these studies reveals a trend toward higher
surgical risks in patients with an occluded contralateral
carotid. Fewer than 10% of CEAs are performed in patients
with contralateral occlusion, compromising the power of
studies analyzing uncommon events such as perioperative
stroke and death.5
Our objective was to conduct a systematic literature
review and determine the comparative efﬁcacy and early
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Volume 57, Number 4 Antoniou et al 1135outcomes of CEA in patients with occluded and patent
contralateral internal carotid arteries.
METHODS
Selection criteria for study enrollment. The objec-
tives of the systematic review, criteria for study inclusion,
and methods of analysis were prespeciﬁed in a protocol.
Studies reporting CEA in patients with and without contra-
lateral internal carotid artery occlusion were eligible for
inclusion and analysis. We attempted to identify all obser-
vational case-control studies speciﬁcally investigating and
comparing the outcomes of CEA in these two well-deﬁned
groups of patients, whereas studies assessing the potential
effects of various factors (including the presence of
contralateral carotid occlusion) on the outcome of CEA
using univariate or multivariate models were not selected.
Studies explicitly reporting that they included patients who
underwent combined CEA and coronary artery bypass
grafting (CABG) were excluded.
We planned to analyze prespeciﬁed outcome measures.
The number of patients allocated to each group and the
number of patients who developed an adverse postopera-
tive event were extracted. Outcome end points were
stroke, transient ischemic attack (TIA), any neurologic
adverse event of cerebral etiology, death of any cause,
and myocardial infarction occurring perioperatively or
#30 days of treatment. All strokes affecting either hemi-
sphere (fatal or nonfatal, contralateral or ipsilateral, result-
ing from hemorrhage or infarction) were included. Where
possible, the Society for Vascular Surgery/American Asso-
ciation for Vascular Surgery reporting standards for carotid
interventions were used to specify and deﬁne the outcome
parameters.7
Literature search methods. A comprehensive and
systematic search of the literature according to the
Preferred Reporting Items for Systematic Reviews and
Meta-Analyses (PRISMA) guidelines was undertaken for
relevant studies.8 The following electronic bibliographic
sources were searched: Medline (1950 to present),
EMBASE (Excerpta Medica Database, 1980 to present),
and AMED (Allied and Complementary Medicine, 1985
to present). The last search was run in August 2012.
Reference lists from retrieved reports were scrutinized
for additional potentially eligible articles. A supplementary
search of related articles suggested by the PubMed search
engine was conducted. Only English-language articles
were considered. Medical subject headings and other
keywords used to identify relevant articles were “carotid
endarterectomy” and “contralateral” and “occlusion.”
Data collection and analysis. Eligibility assessment
for study inclusion in the systematic review and meta-
analysis was performed by one of the authors (G.A.) and
was independently reviewed by a second author (S.A.).
Disagreements were resolved through discussion. The
same two review authors extracted data from the relevant
studies. A data extraction sheet, based on the Cochrane
Consumers and Communication Review Group’s data
extraction template, was developed, pilot-tested in 10randomly selected included studies, and reﬁned accord-
ingly. Extracted information could be divided in four broad
categories:
1. Study characteristics, including year of publication,
patient recruitment period, total number of patients
treated and procedures performed, and inclusion
and exclusion criteria for patient enrollment in the
selected studies;
2. Patient baseline demographic and clinical characteris-
tics, including mean age, sex, presence of hyperten-
sion, coronary artery disease, diabetes mellitus,
dyslipidemia, chronic obstructive pulmonary disease,
chronic renal failure, and smoking;
3. Carotid disease-related and intervention-related
characteristics, including symptomatic or asymptom-
atic carotid disease, imaging modality to diagnose
carotid stenosis and occlusion, use of general and
regional anesthetic, application of shunt during
CEA, and speciﬁc procedure characteristics, such as
conventional or eversion endarterectomy, primary
or patch arteriotomy closure; and
4. Outcome parameters (as outlined above).
We hypothesized that the likelihood that the treat-
ment effect reported in the systematic review approxi-
mates the truth would depend on the validity of the
included studies, because certain methodologic character-
istics might be related with effect sizes. Therefore, to
ascertain the validity of eligible studies, pairs of reviewers
working independently (G.A. and S.A.) appraised the
methodologic quality of the included studies using the
Newcastle-Ottawa scale.9 This assessment tool evaluates
three main methodologic elements of case-control studies:
selection methods (adequate case deﬁnition, representa-
tiveness of the cases, appropriate selection and deﬁnition
of controls), comparability of cases and controls on the
basis of the design or analysis, and assessment of exposure
(ascertainment of exposure, nonresponse rate). This scale
uses a star system, with a maximum of nine stars.
Statistical analysis. Statistical analysis was performed
according to the statistical guidelines for review authors
developed by the Cochrane Review Group. A summary
statistic for each outcome was calculated using a ﬁxed-
effects and a random-effects model. A ﬁxed-effects model
was initially applied to synthesize the data; however, if
signiﬁcant heterogeneity among the included studies was
identiﬁed, random-effects analysis according to DerSimo-
nian and Laird10 was used. Results of all meta-analyses are
presented as odds ratios (ORs) and 95% conﬁdence inter-
vals (CIs) for dichotomous variables using the Mantel-
Haenszel method. Heterogeneity among the studies was
evaluated using a standard c2 test, and we chose a value of
P < .05 as the level of signiﬁcance. We used I2 values for
the assessment of statistical heterogeneity; an I2 value of
$50% indicated the presence of heterogeneity.
Risk of bias was evaluated by constructing funnel plots,
in which the effect for each trial was plotted by the inverse
Fig 1. Literature search strategy. CABG, Coronary artery bypass grafting; CEA, carotid endarterectomy.
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results were subject to reporting or publication bias. In
addition, a mathematic estimate of the asymmetry of this
plot was provided by a linear regression approach (Egger
regression intercept). No sensitivity analysis was under-
taken. Furthermore, we formed meta-regression models
to evaluate the effect of prespeciﬁed covariates on the
main effect measure. Covariates assessed were year of publi-
cation and application of selective or routine shunting.
Pooled data analyses and publication bias tests were per-
formed using the Review Manager 5 software (The Nordic
Cochrane Centre, The Cochrane Collaboration, Copenha-
gen, Denmark). Egger test and meta-regression analyses
were built with Comprehensive Meta-Analysis 2.0 software
(Biostat, Englewood, NJ).
RESULTS
Literature search results and description of studies
The search of the electronic information sources iden-
tiﬁed 42 relevant articles, the full texts of which were exam-
ined in detail. Another four articles were located during the
second-level manual search of the reference lists of the
retrieved articles. Studies published in non-English
language, reporting results of carotid stenting, and
providing inadequate outcome data were not selected, as
outlined in the methodology. We identiﬁed one review
article investigating outcomes of CEA in patients with
patent vs those with an occluded contralateral internal
carotid artery.5 After adjusting for duplicate publications
and those containing overlapping data, 30 articles
remained for inclusion in the analysis.11-40 The analysis
excluded one study41 that included 67 of 557 patients
(12%) undergoing CEA/CABG. The literature search
strategy is depicted in Fig 1.
The total meta-analysis population comprised 27,265
patients having undergone 28,846 CEAs. The selectedstudies included for analysis reported a mean of 931
CEAs (range, 111-5632). Groups of patients with oc-
cluded and patent contralateral carotid arteries included
3120 and 25,726 patients, respectively. The overall patient
recruitment period commenced in 1961 and ﬁnished in
2009. Half of the reports (15 articles) were published after
2000, with the most recent publication in 2012 and the
oldest in 1984.
The inclusion or exclusion criteria for patient enroll-
ment in the studies are inconsistently reported or missing.
Most authors treated symptomatic and asymptomatic
patients with carotid disease, whereas the degree of disease
and the criteria used to deﬁne carotid stenosis varied
considerably among the studies or was not reported.
Several authors did not include patients treated for recur-
rent carotid stenosis or those undergoing CABG or any
other vascular reconstruction at the same setting. Most of
the studies achieved high methodologic quality scores
($7), with a mean number of 6.5 stars. The basic charac-
teristics of the studies included in the analysis are outlined
in Table I.
Modes of imaging investigation used to diagnose carotid
disease and conﬁrm contralateral carotid artery occlusion
varied among the studies, as reported in Table II. Most
studies used digital subtraction angiography as an imaging
assessment tool, whereas a few authors based their diagnosis
on duplex ultrasound imaging alone. Authors treated
asymptomatic vs symptomatic carotid disease at various
percentages; overall, 42% of the patients with contralateral
carotid occlusion were treated for asymptomatic disease,
whereas the corresponding value in the group of patients
with patent contralateral carotid artery was 45%.
The use of regional anesthesia varied among the
studies, with earlier reports (published before 1994) indi-
cating regional anesthesia was not applied in any of their
patients. Most authors of the selected studies used selective
Table I. Study characteristics
Author/year NOS
Recruitment
period
Patients,
No.
CEAs,
No.
Contralateral
carotid
Inclusion criteria Exclusion criteriaOccluded Patent
Goodney/2012 6 2003-2009 5133 5632 353 5279 ND Redo CEA, combined
CEA/CABG
Bagaev/2010 7 1999-2005 335 335 75 260 Symptomatic/
asymptomatic stenosis,
>70% stenosis (ECST)
ND
Maatz/2008 7 1998-2005 1836 1960 161 1799 ND ND
Dalainas/2007 7 1988-2004 2891 3332 373 2959 Symptomatic/
asymptomatic stenosis,
$70% stenosis
Combined CEA/CABG
Grego/2005 7 1997-2002 1381 1445 144 1301 Symptomatic stenosis,
asymptomatic: >70%
stenosis or >60%
stenosis þ contralateral
stenosis >60%/occlusion
Simultaneous
reconstruction of other
cerebral arteries,
combined CEA/CABG,
redo CEA
Fitzpatrick/2005 6 1997-2002 154 170 16 154 ND ND
Cinar/2004 6 1998-2003 429 500 55 445 ND Redo CEA, combined
CABG
Domenig/2003 7 1990-2001 NR 1864 112 1752 ND Combined CEA/CABG/
aortic arch procedures
Ballotta/2002 7 1992-1997 310 336 68 268 Symptomatic/
asymptomatic stenosis,
>60% stenosis
(NASCET)
ND
Rockman/2002 7 1985-1999 NR 2420 338 2082 ND Redo CEA, combined
CEA/CABG
Pulli/2002 7 1996-1999 1324 1324 82 1242 ND ND
Schneider/2002 6 1989-1999 536 564 57 507 ND Redo CEA, combined
CEA/CABG, emergency
CEA for acute carotid
occlusion, external CEA
Karmeli/2001 6 1996-1998 144 144 50 94 Symptomatic/
asymptomatic stenosis,
>70% stenosis
(NASCET)
ND
AbuRahma/2000 7 1991-1995 357 399 49 350 Symptomatic/
asymptomatic stenosis,
>50% stenosis
ND
Locati/2000 7 1988-1998 1266 1266 198 1068 Symptomatic stenosis
>60%, asymptomatic
stenosis >70%
Combined CEA/CABG,
bilateral CEA
Dimakakos/1998 7 1989-1995 235 235 40 195 Symptomatic stenosis $
70%, asymptomatic
stenosis $ 80%
Surgical treatment of
cerebral arteries
Aungst/1998 6 1986-1997 111 111 37 74 Symptomatic/
asymptomatic stenosis,
>60% stenosis
(NASCET)
Combined CEA/CABG
Julia/1998 7 1985-1995 694 694 58 636 ND Combined CEA/CABG
Samson/1998 7 1987-1997 654 654 67 587 Symptomatic stenosis,
asymptomatic: >80% or
>60% stenosis
(NASCET)
ND
daSilva/1996 5 1994 700 700 108 592 ND ND
Frawley/1996 7 1983-1994 259 259 54 205 Symptomatic stenosis,
stenosis >70%
ND
Cao/1995 6 1987-1991 165 165 55 110 ND ND
Deriu/1994 7 1980-1990 375 409 61 348 ND Simultaneous
reconstruction of one or
more other cerebral
arteries
Lacroix/1994 7 1971-1990 618 618 129 489 ND Simultaneous CEA and
arterial reconstruction,
progressive stroke
JOURNAL OF VASCULAR SURGERY
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Table I. Continued.
Author/year NOS
Recruitment
period
Patients,
No.
CEAs,
No.
Contralateral
carotid
Inclusion criteria Exclusion criteriaOccluded Patent
McCarthy/1993 7 1983-1991 526 526 81 445 ND Redo CEA, combined
CEA/CABG, carotid
bypass
Perler/1992 7 1980-1991 187 205 36 169 ND ND
Mattos/1992 7 1976-1991 478 544 66 478 Symptomatic: >50%
stenosis, 30%-50%
stenosis with ulcerated
plaque; asymptomatic:
>80% stenosis, bilateral
stenosis >50%, >50%
stenosis and contralateral
occlusion
Simultaneous carotid-
subclavian bypass,
combined CEA/CABG/
peripheral
revascularization
Mackey/1990 6 1961-1986 598 598 63 535 ND ND
McKittrick/1989 6 1977-1988 370 370 27 343 ND ND
Moore/1984 5 1976-1983 451 510 53 457 ND ND
CABG, Coronary artery bypass grafting; CEA, carotid endarterectomy; ECST, European Carotid Surgery Trial; NASCET, North American Symptomatic
Carotid Endarterectomy Trial; ND, not deﬁned; NOS, Newcastle-Ottawa scale.
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ence, symptoms of cerebral ischemia during cross-clamping
in awake patients, stump pressure, electroencephalographic
changes, reduction in middle cerebral artery velocity on
transcranial Doppler, or changes in somatosensory-evoked
potentials in patients receiving general anesthesia. Five
studies applied routine shunting during CEA, and another
three studies did not use shunting in any patients. Pooled
analyses revealed that patients with occlusion of the contra-
lateral internal carotid artery were more likely to have had
a shunt during the procedure than patients with a patent
contralateral carotid artery (67% vs 47%, respectively).
Procedure-related and technical characteristics are detailed
in Table II.
Synthesis of results and outcome
Stroke. All but one study reported stroke rates #30
days of treatment. The incidence of stroke was 3.3% in
the occluded contralateral carotid group and 1.9% in the
patent contralateral carotid group (OR, 1.65; 95% CI,
1.30-2.09; P < .001; Fig 2). No signiﬁcant heterogeneity
among the studies was identiﬁed (I2 ¼ 0%), and the
possibility of publication bias was low (P ¼ .07).
Transient ischemic attack. TIAs #30 days of the
procedure were reported in 21 studies. Patients with
contralateral internal carotid artery occlusion had an
increased risk of developing TIA compared with patients
with a patent contralateral carotid artery (2.2% vs 1.4%,
respectively; OR, 1.57; 95% CI, 1.11-2.21; P ¼ .01;
Fig 3). No signiﬁcant heterogeneity among the studies
existed (I2 ¼ 0%), and the likelihood of publication bias
was low (P ¼ .06).
Stroke plus TIA. The total incidence of neurologic
events (stroke plus TIA) was reported in 22 studies. CEA
in the presence of contralateral carotid artery occlusion
was associated with an increased risk of adverse neurologicevents of cerebral etiology #30 days of treatment
compared with CEA performed in patients with a patent
contralateral internal carotid artery (4.9% vs 2.9%, respec-
tively; OR, 1.52; 95% CI, 1.21-1.90; P ¼ .0003; Fig 4).
No signiﬁcant heterogeneity among the studies was present
(I2 ¼ 0%), and the possibility of publication bias was low
(P ¼ .383).
Death. Perioperative (#30 days) mortality rates were
reported in 28 studies. The mortality risk of patients with
an occluded contralateral internal carotid artery was signif-
icantly higher than that in patients with a patent contralat-
eral carotid artery (1.1% vs 0.5%, respectively; OR, 1.76;
95% CI, 1.19-2.59; P ¼ .004; Fig 5). No heterogeneity
among the studies existed, and the possibility of publica-
tion bias was low (P ¼ .569).
Myocardial infarction. Eight studies reported
cardiac complications occurring #30 days of treatment.
No difference in the incidence of myocardial infarction
between groups with an occluded contralateral carotid
and a patent contralateral carotid was identiﬁed (0.9% vs
0.7%, respectively; OR, 1.45; 95% CI, 0.73-2.89;
P ¼ .29; Fig 6). No heterogeneity among the studies
was found, and the possibility of publication bias was low
(P ¼ .170).
Meta-regression analysis. Meta-regression analysis
was used to investigate the effect of publication date of
each study contributing to the meta-analysis on the
outcome measures. We found no statistically signiﬁcant
association between the time of publication and the likeli-
hood of developing perioperative (#30 days) stroke (P ¼
.076), TIA (P ¼ .612), stroke plus TIA (P ¼ .589), and
death (P ¼ .517; Fig 7). There was no signiﬁcant hetero-
geneity of outcome in the population of patients who had
routine or selective shunting; therefore, further analysis was
not performed.
Table II. Carotid disease-related and intervention-related characteristics
Author/year Imaging
Asymptomatic
disease, %
Regional
anesthesia, % Shunting, %
Procedures in CO vs CP group
CO
group
CP
group
CO
group
CP
group
CO
group
CP
group
Goodney/2012 NR 61 45 7 12 67 47 Patch/primary closure, 319/
353 (90%) vs 4715/5279
(89%); eversion
endarterectomy, 34/353
(10%) vs 564/5279 (11%)
Bagaev/2010 NR 59 66 1 1 100 100 Patch/primary closure [patch
closure, 75/75 (100%) vs
259/260 (99.6%); direct
closure, 0/75 (0%) vs 1/260
(0.4%)]
Maatz/2008 NR 59 65 NR NR 100 100 Patch closure
Dalainas/2007 US or DSA or MRA (DSA in
dubious cases)
53 60 91 89 29 7 Patch/primary closure, eversion
endarterectomy
Grego/2005 US þ DSA/MRA (90 patients
US only, DSA if discrepancy
between US/MRA and in
carotid occlusion)
32 37 0 0 100 100 Patch closure, 115/144 (80%) vs
1020/1301 (78%); eversion
endarterectomy, 27/144
(19%) vs 256/1301 (20%);
bypass, 2/144 (1%) vs
25/1301 (2%)
Fitzpatrick/2005 NR 50 55 13 39 69 47 Patch closure, 14/16 (88%) vs
122/154 (79%)
Cinar/2004 US with/without
DSA/MRA
NR NR 100 100 11 9 NR
Domenig/2003 US with/without DSA/MRA 52 50 16 15 82 77 Patch closure, 69/112 (62%) vs
1174/1752 (67%)
Ballotta/2002 US þ DSA 38 39 0 0 53 5 Patch closure, 39/68 (57%) vs
128/268 (48%); eversion
endarterectomy, 29/68 (43%)
vs 140/268 (52%)
Rockman/2002 US þ DSA/MRA (DSA if US/
MRA inconclusive)
34 38 72 83 66 27 Patch closure
Pulli/2002 US þ DSA 64 60 0 0 NR NR NR
Schneider/2002 US or DSA 32 36 0 0 55 13 Patch/primary closure, eversion
endarterectomy
Karmeli/2001 US þ CTA (with/without DSA) 76 40 92 92 42 6 NR
AbuRahma/2000 US þ DSA 51 48 0 0 100 100 Patch/primary closure
Locati/2000 US þ DSA 25 30 100 100 83 9 Patch/primary closure
Dimakakos/1998 US þ DSA 50 45 0 0 0 0 Primary closure
Aungst/1998 US þ DSA 27 37 0 0 NR NR Patch closure, 36/37 (97%) vs
70/74 (95%)
Julia/1998 NR 26 40 0 0 10 0.3 NR
Samson/1998 US or DSA (or both) 29 24 0 0 0 0 Patch/primary closure
daSilva/1996 NR 7 8 NR NR 83 65 NR
Frawley/1996 DSA 0 0 0 0 0 0 NR
Cao/1995 DSA 25 61 60 65 31 5 Patch closure, 31/55 (56%) vs
59/110 (54%)
Deriu/1994 US þ DSA 20 27 0 0 NR NR Patch closure
Lacroix/1994 US with/without DSA 33 31 0 0 87 31 Patch/primary closure, 121/
129 (94%) vs 396/489 (81%)
McCarthy/1993 DSA 43 30 0 0 NR NR Patch closure, 16/81 (20%) vs
129/445 (29%)
Perler/1992 DSA 22 23 0 0 NR NR Patch/primary closure [patch
closure, 18/36 (50%) vs 72/
169 (43%)]
Mattos/1992 DSA 23 27 0 0 98 69 Patch closure, 24/66 (36%) vs
174/478 (36%)
Mackey/1990 DSA 43 28 0 0 NR NR NR
McKittrick/1989 US or DSA 30 32 0 0 11 2 NR
Moore/1984 DSA NR NR 0 0 NR NR NR
CO, Contralateral occlusion; CP, contralateral patent; CTA, computed tomography angiography; DSA, digital subtraction angiography; MRA, magnetic
resonance angiography; NR, not reported; US, ultrasound.
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Fig 2. Forest plot shows comparison of stroke rates between the contralateral carotid occluded and contralateral
carotid patent groups. CI, Conﬁdence interval; M-H, Mantel-Haenszel.
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The beneﬁcial effects of surgical intervention for
symptomatic and asymptomatic patients with carotid
disease on stroke prevention are well-established.1
Patients with stenosis of one carotid artery and concomi-
tant occlusion of the contralateral internal carotid artery
constitute a particular group of patients who are likely
to have progressive disease and subsequent stroke.42
Concerns have been postulated with regard to the early
operative results in this subset of patients undergoing
CEA and the speciﬁc impact of contralateral vessel occlu-
sion on perioperative risks for cerebrovascular complica-
tions and death.2,3 Our analysis revealed increased risk
of early adverse neurologic events in this group of
patients; however, no data on the mechanism of stroke
are provided in the meta-analysis. Apart from cerebral
ischemia and hemorrhage, technical issues associated
with thrombosis or embolism have also been shown to
be common causes of perioperative stroke in patients
undergoing CEA.
The current review identiﬁed several publications
investigating speciﬁc risks of patients with contralateral
carotid occlusion undergoing CEA compared with thoseof a control group. Conﬂicting evidence creates confusion
about the appropriate management of these patients, with
most of the reports asserting safety of surgical intervention
contralateral to an occluded carotid vessel, whereas a few
authors only demonstrate higher estimates of adverse peri-
operative events attributed to the occluded vessel and
insufﬁcient cerebral circulatory reserve.5
Interestingly, and contrary to the results of previous
reports, our analyses revealed increased risk of stroke,
TIA, and all-cause mortality #30 days of surgical interven-
tion in patients with an occluded contralateral internal
carotid artery. However, none of these factors reached an
OR of 2.0, which reduces the clinical signiﬁcance of our
ﬁndings. The discrepancy between the results of our anal-
ysis and those of previously published work may be
explained by reduced power of the selected studies. A small
proportion of patients undergoing CEA present with
occlusion of the contralateral artery, and large numbers
of patients are required to produce meaningful compari-
sons with regard to rare events such as perioperative stroke
and death.
Our ﬁndings are consistent with the results of the
Society for Vascular Surgery Vascular Registry, which
Fig 3. Forest plot shows comparison of transient ischemic attack rates between the contralateral carotid occluded and
contralateral carotid patent groups. CI, Conﬁdence interval; M-H, Mantel-Haenszel.
Fig 4. Forest plot shows comparison of combined stroke/transient ischemic attack rates between the contralateral
carotid occluded and contralateral carotid patent groups. CI, Conﬁdence interval; M-H, Mantel-Haenszel.
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contralateral carotid occlusion and 10,948 with a patent
contralateral internal carotid artery.6 This study found
increased risk of stroke in patients with contralateralcarotid occlusion compared with patients with a patent
contralateral carotid artery (1.06% vs 3.15%, respectively;
P < .001); this difference persisted even after comparing
homogenous groups of patients by symptomatic or
Fig 5. Forest plot shows comparison of mortality rates between the contralateral carotid occluded and contralateral
carotid patent groups. CI, Conﬁdence interval; M-H, Mantel-Haenszel.
Fig 6. Forest plot shows comparison of myocardial infarction rates between the contralateral carotid occluded and
contralateral carotid patent groups. CI, Conﬁdence interval; M-H, Mantel-Haenszel.
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the ascertainably improved results of CEA in this
subgroup of patients in recent studies compared with
earlier reports, we sought to investigate whether treat-
ment effects varied with the year the study was conduct-
ed; meta-regression analysis revealed no signiﬁcant impact
of the time studies were published on the overall outcome
estimates (Fig 7).Before interpreting the results of the present analysis
and embarking on suggestions regarding their implica-
tions in clinical practice, we should attempt an insight
in the methodology and characteristics of the studies
selected for analysis. This review is limited because the
degree of stenosis, indication for treatment, and the
exclusion of recurrent stenosis varied widely among the
studies. Variability in the methods used for diagnosing
Regression of Year of publication on Log odds ratio
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Fig 7. Relationship between year of publication and log odds ratio is shown for stroke.
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ment also existed. Duplex ultrasound imaging alone was
applied to determine occlusion of the carotid artery by
several authors. Series in which the diagnosis of occlusion
was made on the basis of ultrasound imaging will overes-
timate the frequency of occlusion. Current recommenda-
tions are that more than one modality should be used to
conﬁrm carotid occlusion. In addition, the status of
collateral vertebrobasilar circulation was inconsistently
examined and reported by the authors or was not re-
ported at all.
Most studies combined symptomatic and asymptom-
atic patient populations. The Asymptomatic Carotid
Atherosclerosis Study investigators, having examined
asymptomatic patients only, found similar risk in patients
with an occluded and patent contralateral carotid artery
and suggested that studies evaluating symptomatic
patients, such as the NASCET and the European Carotid
Surgery Trial, observed higher morbidity and mortality
among surgically treated patients with contralateral occlu-
sion, possibly because of the poorer collateral cerebral
circulation in this group.3,4,43
Considerable variability in intraoperative practices for
cerebral protection also existed. Although different authors
used different methods and criteria for shunt use, a shunt
was more likely to be inserted in patients with contralateral
carotid occlusion than in patients with a patent contralateral
vessel (67% vs 47%), which underlines the reduced cerebral
circulatory reserve in these patients. Furthermore, signiﬁ-
cant variability in anesthetic methods and surgical tech-
niques has not been taken into account in the calculation
of surgical outcomes, which limits the ﬁndings of our anal-
ysis. In addition, lack of objective and accurate evaluation
of postoperative neurologic complications, such as the Ran-
kin index, was observed in the studies selected for analysis.
CONCLUSIONS
Careful selection of patients is required when consid-
ering carotid surgery. Symptom status, degree of stenosis,
other risk factors, and evaluation of the vertebrobasilarand intracerebral collateral circulation will aid in selection.
Moreover, intraoperative cerebral monitoring and selective
application of cerebral protection may minimize adverse
cerebrovascular events in these high-risk patients. Ad-
vanced postoperative monitoring and management,
including blood pressure control, antiplatelet agents, and
early recognition of neurologic complications, by appropri-
ately trained staff in a high-dependency unit, should be
instituted to optimize outcomes in patients with contralat-
eral carotid occlusion.
These measures are simply standard best practice
regarding intraoperative and perioperative management
when performing CEA. Speciﬁc suggestions regarding
the selection and management of patients with contralat-
eral occlusion undergoing CEA cannot be made based
on the available evidence. Future research should focus
on conducting multicenter studies and establishing
national and international registries providing reliable
data from homogenous groups of patients who undergo
CEA using speciﬁc anesthetic and operative methods.
Carotid angioplasty and stenting has been proposed for
the treatment of high-surgical risk patients, including those
with contralateral carotid artery occlusion.44,45 It remains
unknown whether such methods minimize surgical risks
resulting from cerebral ischemia and intraoperative neuro-
logic complications during carotid cross-clamping. Data
from the Society for Vascular Surgery Carotid Registry
have shown that whereas CEA is preferred in patients
with a nonoccluded contralateral carotid artery, regardless
of symptom status, based on lower periprocedural death
and stroke, the beneﬁt of CEA is lost in patients with
contralateral occlusion because of increased stroke rates
in contralateral carotid occlusion patients after CEA but
not angioplasty and senting.6 Further studies are needed
to compare surgery and carotid stenting in these high-
risk patients. The current meta-analysis suggests the pres-
ence of contralateral carotid occlusion is an increased risk
factor for carotid surgery. Careful consideration should
be given in selection and in perioperative and postoperative
care in these patients.
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